Yesterday Keryx Biopharmaceuticals (NDAQ:KERX) traded 0.00% even at $6.82. The company’s 50-day moving …
Keryx Biopharmaceuticals Inc. (KERX) had a good day on the market for Friday ... of Keryx Biopharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for KERX. Keryx Biopharmaceuticals Inc. is also a …
Netflix (NASDAQ: NFLX) 15.2% HIGHER; reported Q4 EPS of $0.72, $0.27 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion. Domestic steaming …
I read this article and found it very interesting, thought it might be interesting for you. The article is called Keryx …
Forward Price to Sales Ratio is the current stock price over the predicted sales per share. While similar to the price to sales ratio, this is a forward looking estimate of a company's sales. A forward P/S ratio that is higher than the current …
What: Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) gained more than 20% in early morning trading today due to an upgrade from FBR Capital. The firm upped Keryx's stock from market perform to outperform and increased its 12 …
KERX's rating was lowered to the equivalent of a "hold" at Brean Capital, FBR, and Stifel, while JMP, Ladenburg Thalmann, and Raymond James cut their price targets. Out of the gate, the stock is down 9% at $4.30, following yesterday' post …
Request more information now by clicking here: www.faruqilaw.com/KERX. There is no cost or obligation to you. Take Action If you currently own Keryx stock and have ... faruqi-llp-is-investigating-keryx-biopharmaceuticals-inc-kerx
Keryx Biopharmaceuticals Inc. KERX, +1.39% shares were halted in pre-market trade Monday and the company said …